Parabilis Medicines, Inc. Cash and Restricted Cash
Parabilis Medicines, Inc. (PBLS) had Cash and Restricted Cash of $1.09 billion as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.09B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.57M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $83.25M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $50.14M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-08-13 |
| 2025-12-31 | $30.57M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $83.25M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $50.14M 10-Q · filed 2026-08-13 |